Kaushik  Ghoshal net worth and biography

Kaushik Ghoshal Biography and Net Worth

Insider of ResMed
Kaushik Ghoshal is the Pres of SaaS Bus. & CTO at Resmed.

What is Kaushik Ghoshal's net worth?

The estimated net worth of Kaushik Ghoshal is at least $1.94 million as of July 13th, 2023. Mr. Ghoshal owns 11,787 shares of ResMed stock worth more than $1,944,266 as of December 6th. This net worth estimate does not reflect any other investments that Mr. Ghoshal may own. Additionally, Mr. Ghoshal receives an annual salary of $1,110,000.00 as Insider at ResMed. Learn More about Kaushik Ghoshal's net worth.

How old is Kaushik Ghoshal?

Mr. Ghoshal is currently 55 years old. There are 6 older executives and no younger executives at ResMed. The oldest executive at ResMed is Dr. Peter C. Farrell A.M., B.E., BE, who is 81 years old. Learn More on Kaushik Ghoshal's age.

What is Kaushik Ghoshal's salary?

As the Insider of ResMed Inc., Mr. Ghoshal earns $1,110,000.00 per year. There are 3 executives that earn more than Mr. Ghoshal. The highest earning executive at ResMed is Mr. Michael J. Farrell BE, MBA, SM, CEO & Chairman, who commands a salary of $2,870,000.00 per year. Learn More on Kaushik Ghoshal's salary.

How do I contact Kaushik Ghoshal?

The corporate mailing address for Mr. Ghoshal and other ResMed executives is 9001 SPECTRUM CENTER BLVD., SAN DIEGO CA, 92123. ResMed can also be reached via phone at (858) 836-5000 and via email at [email protected]. Learn More on Kaushik Ghoshal's contact information.

Has Kaushik Ghoshal been buying or selling shares of ResMed?

Kaushik Ghoshal has not been actively trading shares of ResMed within the last three months. Most recently, Kaushik Ghoshal sold 500 shares of the business's stock in a transaction on Thursday, July 13th. The shares were sold at an average price of $220.00, for a transaction totalling $110,000.00. Following the completion of the sale, the insider now directly owns 11,787 shares of the company's stock, valued at $2,593,140. Learn More on Kaushik Ghoshal's trading history.

Who are ResMed's active insiders?

ResMed's insider roster includes Carol Burt (Director), Robert Douglas (COO), Karen Drexler (Director), Michael Farrell (CEO), Peter Farrell (Director), Kaushik Ghoshal (Insider), James Hollingshead (Insider), Justin Leong (Insider), David Pendarvis (Insider), Michael Rider (General Counsel), Brett Sandercock (CFO), Rajwant Sodhi (Insider), and Ronald Taylor (Director). Learn More on ResMed's active insiders.

Are insiders buying or selling shares of ResMed?

In the last twelve months, insiders at the medical equipment provider sold shares 38 times. They sold a total of 103,723 shares worth more than $21,132,918.44. The most recent insider tranaction occured on November, 27th when CFO Brett Sandercock sold 3,000 shares worth more than $457,860.00. Insiders at ResMed own 1.2% of the company. Learn More about insider trades at ResMed.

Information on this page was last updated on 11/27/2023.

Kaushik Ghoshal Insider Trading History at ResMed

Transaction DateBuy/SellNumber of SharesAverage Share PriceTotal TransactionShares Held After TransactionDetails
7/13/2023Sell500$220.00$110,000.0011,787View SEC Filing Icon  
6/2/2023Sell500$220.00$110,000.0012,287View SEC Filing Icon  
5/1/2023Sell500$239.30$119,650.0012,704View SEC Filing Icon  
4/24/2023Sell2,000$230.00$460,000.0013,204View SEC Filing Icon  
See Full Table

Kaushik Ghoshal Buying and Selling Activity at ResMed

This chart shows Kaushik Ghoshal's buying and selling at ResMed by year and by quarter.

Skip ChartChart Data in Insider Trading History Table

ResMed Company Overview

ResMed logo
ResMed Inc. develops, manufactures, distributes, and markets medical devices and cloud-based software applications for the healthcare markets. It operates in two segments, Sleep and Respiratory Care, and Software as a Service. It offers various products and solutions for a range of respiratory disorders, including technologies to be applied in medical and consumer products, ventilation devices, diagnostic products, mask systems for use in the hospital and home, headgear and other accessories, dental devices, and cloud-based software informatics solutions to manage patient outcomes, as well as provides customer and business processes. The company also provides AirView, a cloud-based system that enables remote monitoring and changing of patients' device settings; myAir, a personalized therapy management application for patients with sleep apnea that provides support, education, and troubleshooting tools for increased patient engagement and improved compliance; U-Sleep, a compliance monitoring solution that enables home medical equipment (HME) to streamline their sleep programs; connectivity module and propeller solutions; and Propeller portal. It offers out-of-hospital software solution, such as Brightree business management software and service solutions to providers of HME, pharmacy, home infusion, orthotics, and prosthetics services; MatrixCare care management and related ancillary solutions to senior living, skilled nursing, life plan communities, home health, home care, and hospice organizations, as well as related accountable care organizations; HEALTHCAREfirst that offers electronic health record, software, billing and coding services, and analytics for home health and hospice agencies; and MEDIFOX DAN's software solutions. The company markets its products to sleep clinics, home healthcare dealers, and hospitals through a network of distributors and direct sales force. The company was founded in 1989 and is headquartered in San Diego, California.
Read More

Today's Range

Now: $164.95
Low: $162.80
High: $165.35

50 Day Range

MA: $147.77
Low: $134.74
High: $161.53

2 Week Range

Now: $164.95
Low: $132.24
High: $243.52

Volume

312,549 shs

Average Volume

990,569 shs

Market Capitalization

$24.26 billion

P/E Ratio

26.78

Dividend Yield

1.20%

Beta

0.55